Ensuring that there is adequate representation in clinical trials is important for a whole host of reasons, but achieving diversity is easier said than done. 

In this episode of the Public Health Insight Podcast, we speak to a leader of a company that is finding unique ways to leverage data and engage populations often excluded from clinical trials.  


Podcast Guest

◼️ Eddilisa Martin, PharmD, Founder & CEO of M&B Sciences Inc.

References In Our Discussion

◼️ FDA Says Diversity Now Required In Clinical Trials 

◼️ Why Representation Matters In Clinical Trials

◼️ Importance Of Diverse Populations In Clinical Trials 


Podcast Hosts

◼️ Gordon Thane, BMSc, MPH, PMP®

◼️ Leshawn Benedict, MPH, MSc, PMP®


Subscribe to the Newsletter

Subscribe to the newsletter so you don’t miss out on the latest podcast episodes, live events, job skills, learning opportunities, and other engaging professional development content here.


Leave Us A Five Star Rating

If you enjoy our podcasts, be sure to subscribe and leave us a rating on Apple Podcast or Spotify, and spread the word to your friends to help us get discovered by more people.

Send us a Text Message to let us know what you think.